首页 > 文献资料库 > 详情

Randomized, Controlled, Multicentered, Double-Blind Investigation of Injectable Poly-L-Lactic Acid f

Krista Bohnert, BS, Andrew Dorizas, MD, Paul Lorenc, MD, and Neil S. Sadick, MD


你可能喜欢...

08-12

2021

Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observation

This study demonstrated, in real-life conditions and on a large sample, that PLLA injections were feasible, efficient, and safe when performed by trained physicians.

08-12

2021

Multicenter Prospective Cohort Study of the Incidence of Adverse Events Associated With Cosmetic Der

09-22

2021

Consensus Recommendations on the Use of Injectable Poly-L-Lactic Acid for Facial and Nonfacial Volum

Poly-L-lactic acid (PLLA) was approved for use in Europe in 1999. In the United States, it was approved by the Food and Drug Administration in 2004 for the treatment of facial lipoatrophy associated with human immunodeficiency virus, and in 2009 for cosm